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DObjective: Fenestration during Fontan palliation has traditionally been used to decrease surgical morbidity and
mortality, particularly in high-risk cases. Potential limitations include oxygen desaturation, risk of paradoxic em-
bolism, and need for late intervention. Our practice has evolved away from routine fenestration with increased
extracardiac conduit use. We reviewed our experience with Fontan palliation and retrospectively assessed out-
comes with decreased fenestration.
Methods: Between January 2002 and April 2008, 226 patients underwent primary Fontan palliation. Outcomes
were assessed by hospital stay, chest drain duration, short- and long-term survivals, and late interventions.
Results: Anatomic subtypes were single left ventricle (n ¼ 88, 38.9%), single right ventricle (n ¼ 78, 34.5%),
common ventricle (n ¼ 19, 8.4%), and heterotaxy syndrome (n ¼ 41, 18.1%). Lateral tunnel connection was
created in 69 patients (30.5%); extracardiac connection was created in 157 (69.5%). Mean age and weight at sur-
gery were 4.3 3.8 years and 17.2 9 kg, respectively. In 2002, 14 of 16 patients (87.5%) had fenestrated Fon-
tan circulations, versus 2 of 32 (6.3%) in 2008. Mean hospital stay was 10.8 8.8 days. Survival to discharge or
30 days was 98.7%. There were 2 (0.9%) late deaths during mean follow-up of 2.0 1.7 years. Outcomes were
equivalent between fenestrated and nonfenestrated procedures across anatomic subtypes.
Conclusions: Highly selective use of Fontan fenestration is achievable while maintaining excellent outcomes
without increased surgical morbidity or mortality, irrespective of anatomic subtype. Risks of hypoxia, systemic
embolism, and late instrumentation can be avoided in most cases. (J Thorac Cardiovasc Surg 2010;140:129-36)Since first being introduced in 1971 byDr Francis Fontan, the
Fontan palliation for patients with single-ventricle anatomy
has undergone significant evolution.1 From the atriopulmo-
nary Fontan procedure first put forward for repair of tricuspid
atresia, surgical approaches have transitioned to a total cavo-
pulmonary anastomosis with an intracardiac lateral tunnel
and, most recently, the extracardiac Fontan connection.2-5
Potential challenges encountered with Fontan physiology
include lowpostoperative cardiac output, pleural and pericar-
dial effusions, ascites, ventricular dysfunction, diminished
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The Journal of Thoracic and CaRoutine fenestration of the Fontan circuit has been used to
combat these morbidities and to improve operative
survival.9-11 Despite the apparent benefits of fenestration,
drawbacks include the risks of systemic embolization,
systemic desaturation, and need for late catheter
interventions for fenestration closure.9,12,13
The improved hemodynamics and durability, decreased
atrial arrhythmias, and relative technical ease of the extracar-
diac Fontanmodification have led to itswidespread use for all
single-ventricle anatomic subtypes.14,15 Greater reliance on
the extracardiac technique has facilitated these palliations
by the avoidance of cardiac arrest, systemic cooling, and
extensive atrial manipulation—all variables that have been
shown to have a negative effect on survival.16,17 Evolution
in perioperative management strategies has further improved
outcomes, with advances in anesthetic techniques, perfusion
strategies, and postoperative care translating into increased
surgical success.
Building on these improvements, our center has devel-
oped a highly selective approach to Fontan fenestration,
limiting its application only to very high-risk patients. The
purpose of this studywas to review our outcomeswith highly
selective Fontan fenestration across all anatomic subtypes.
MATERIALS AND METHODS
A retrospective analysis of all primary Fontan palliations performed at
Texas Children’s Hospital between January 1, 2002, and December 31,rdiovascular Surgery c Volume 140, Number 1 129
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D2008 was completed with the permission of the institutional review board of
Baylor College of Medicine. There were 226 consecutive Fontan palliations
performed, with none excluded. Long-term outcomes were determined from
review of patient follow-up records at Texas Children’s Hospital and re-
cords of referring physicians.
The mean age and weight at operation were 4.3  3.8 years and 17.2 
9.0 kg, respectively, and 42% (n ¼ 95) were female. On preoperative eval-
uation, atrioventricular valve regurgitation was moderate or greater in 4.4%
(n ¼ 10). Mean transpulmonary gradient was 4.1  2.4 mm Hg, and mean
pulmonary vascular resistance was 1.4  0.72 Woods units.
Anatomic subtypes were categorized as single left ventricle (n ¼ 88,
38.9%), single right ventricle including hypoplastic left heart syndrome
(n ¼ 78, 34.5%), common ventricle including unbalanced atrioventricular
canal (n¼ 19, 8.4%), and heterotaxy syndrome (n¼ 41, 18.1%). Concom-
itant procedures at the time of Fontan palliation included atrioventricular
valve repair (n¼ 16, 7.1%), aortic reconstruction (n¼ 2, 0.9%), atrial sep-
tectomy (n ¼ 36, 15.9%), pulmonary artery plasty (n ¼ 60, 26.5%), main
pulmonary artery division (n ¼ 11, 4.9%), pacemaker implantation (n ¼ 7,
3.1%), peritoneal dialysis catheter placement (n¼ 54, 23.9%), and ligation
of Blalock–Taussig shunt (n ¼ 8, 3.5%).
The surgical technique used for Fontan palliation was either intracardiac
lateral tunnel or extracardiac conduit. Lateral tunnel procedures were per-
formed under conditions of cardiopulmonary bypass (CPB) with aortic
crossclamping, cardioplegic electromechanical arrest, and moderate sys-
temic cooling. Polytetrafluoroethylene (GORE-TEX;W. L. Gore & Associ-
ates, Inc, Flagstaff, Ariz) patch material was used to baffle the inferior vena
cava to the Glenn cavopulmonary connection through the right atrial ap-
pendage, and a 2.5- to 4-mm fenestrationwas created routinelywith a punch.
Extracardiac palliation was performed under conditions of CPB with mild
hypothermia, without cardiac arrest, and with GORE-TEX conduits ranging
in size from 16 to 24 mm, with sizes 18 and 20 predominating. The GORE-
TEX extracardiac conduit was anastomosed to the underside of the pulmo-
nary arteries offset from the Glenn connection and then sewn end-to-end
into the divided inferior vena cava.
The CPB circuit (Terumo with RX-15 hollow-fiber oxygenator; Terumo
Medical Corporation, Tokyo, Japan) minimized priming volumes (650mL),
and the pump prime was made as physiologically normal as possible. The
pump prime hematocrit was such that the hematocrit during CPB was
greater than 30%, and the prime was ultrafiltered (Hemocor; Minntech Cor-
poration, Minneapolis, Minn) as necessary before CPB to ensure physio-
logic blood chemistry and glucose values. In addition to packed red blood
cells, fresh-frozen plasma and 25% albumin were used for the prime to
maintain oncotic pressure. On CPB, continuous zero-balance ultrafiltration
was performed for removal of free water and inflammatory mediators. CPB
flows were maintained to achieve a 2.8 cardiac index irrespective of sys-
temic temperature, and the target hematocrit after CPB was greater than
35%. When aortic crossclamping was required, a buffered, crystalloid car-
dioplegia solution was administered every 20 minutes. Since 2005, a policy
of early extubation after Fontan palliation has been in place, with most pa-
tients extubated in the operating room.
Statistical Methods
Descriptive statistics for nominal and numeric data included ratio and
mean  SD. The c2 test was used to compare categoric variables, and the
Student t test was used to compare continuous variables. Multivariate anal-
ysis was performed with regression models (linear for continuous variables
and logistic for categoric variables) to study the effects of selected factors on130 The Journal of Thoracic and Cardiovascular Surgoutcome variables. All analyses were conducted with SPSS 13.0 (SPSS Inc,
An IBM Company, Chicago, Ill).RESULTS
The decreasing use of Fontan fenestration at our center is
demonstrated in Table 1. The data presented reflect the total
numbers of primary Fontan palliations by anatomic subtype
and the percentages of each that were fenestrated. In 2008,
only 2 of 32 palliations (6%) were fenestrated.
Operative data by Fontan surgical technique are listed in
Table 2. Mean aortic crossclamp times in minutes, CPB
times in minutes, and lowest systemic temperatures during
cooling are listed for extracardiac and lateral tunnel tech-
niques. Intracardiac concomitant procedures were per-
formed in 24 patients receiving extracardiac conduits
(15.3%), compared with 26 patients receiving lateral tunnels
(37.7%).
The relative distribution of extracardiac versus lateral tun-
nel procedures is graphically displayed in Figure 1. As use of
the extracardiac technique has increased, overall Fontan fen-
estration (solid line) has steadily decreased. Currently, fen-
estration use is highly selective among patients receiving
extracardiac tunnels and still common among those receiv-
ing lateral tunnels.
Early extubation was defined as occurring in the operating
room or at any time during the day of surgery. The rate of
early extubation has increased steadily during the study pe-
riod, across all anatomic subtypes. The rate of early extuba-
tion went from 6.3% (n ¼ 1) in 2002 to 93.8% (n ¼ 30) in
2008. Early extubation was accomplished in 106 of 157 pa-
tients receiving extracardiac conduits (67.5%), in contrast to
31 of 69 patients receiving lateral tunnels (44.9%,
P ¼ .001).
Results with decreasing fenestration use are presented in
Table 3. Early and late measures of outcome are represented.
An early death was defined as one occurring before discharge
or within 30 postoperative days. Early death occurred in 3
cases (1.3%). One death occurred after an extracardiac Fon-
tan procedure (nonfenestrated) in the setting of dextrocardia,
unbalanced atrioventricular canal, and heterotaxy syndrome.
The patient had previously undergone bilateral, bidirectional
cavopulmonary shunts in the setting of interrupted inferior
vena cava (Kawashima). After an initially stable postopera-
tive period, hypotension and ventricular fibrillation devel-
oped and were refractory to resuscitation efforts and
reopening of the sternum. A second early death occurred af-
ter fenestrated extracardiac Fontan procedure in a patient
with hypoplastic left heart syndrome and severe reactive air-
way disease. This patient demonstrated significantly ele-
vated pulmonary vascular resistance postoperatively and
ultimately died of multisystem organ failure. The third early
death occurred after total cavopulmonary connection includ-
ing fenestrated lateral tunnel Fontan procedure in the setting
of trisomy 21 and unbalanced atrioventricular canal inery c July 2010
TABLE 1. Fenestration of primary Fontan procedure by anatomic subtype
Anatomy 2002 2003 2004 2005 2006 2007 2008 Total
Single left ventricle 5 (100%) 15 (60%) 7 (14%) 14 (29%) 16 (31%) 17 (12%) 14 (7%) 88 (31%)
Single right ventricle 4 (100%) 7 (71%) 13 (54%) 14 (57%) 14 (43%) 16 (56%) 10 (10%) 78 (51%)
Hypoplastic left
heart syndrome
2 (100%) 2 (100%) 8 (62%) 8 (75%) 9 (56%) 11 (36%) 7 (0%) 47 (51%)
Common ventricle 2 (50%) 4 (100%) 3 (0%) 5 (100%) 1 (0%) 2 (0%) 2 (0%) 19 (53%)
Heterotaxy 5 (80%) 5 (40%) 4 (100%) 7 (14%) 8 (37%) 6 (67%) 6 (0%) 41 (44%)
Total 16 (87%) 31 (64%) 27 (44%) 40 (45%) 39 (36%) 41 (37%) 32 (6%) 226 (42%)
Data reflect total Fontan procedures performed and percentage with fenestration. Hypoplastic left heart syndrome is listed as a subset of single right ventricle.
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The patient underwent fenestration closure on postoperative
day 2 in response to hypoxia. After mechanical pleurodesis
for pleural effusion, the patient died of cardiovascular col-
lapse. There have been no early deaths since January 2005.
Two late deaths occurred among patients undergoing Fontan
procedures before 2004. One death occurred late after trans-
plantation in the setting of hypoplastic left heart syndrome.
The second late death, of unclear etiology, occurred after de-
vice closure of a fenestrated lateral tunnel Fontan procedure.
Comparison of early outcomes between fenestrated
(n ¼ 95) and nonfenestrated (H ¼ 131) Fontan palliations
is displayed in Table 4. Presented are the of days of intuba-
tion after surgery, intensive care unit stay, hospital stay, and
number of days with chest tube in place. In-hospital mortal-
ity and early readmission (within 1 month of discharge) rate
are also presented. Early outcomes for patients with nonfe-
nestrated procedures were equal to or better than those for
patients with fenestrated procedures. As noted previously,
patients with fenestrated lateral tunnels predominated in
the early years of this study. Furthermore, lateral tunnel pro-
cedures were associated with more intracardiac concomitant
procedures than were extracardiac procedures.
The median duration of intubation after surgery for pa-
tients with fenestration was 1 day (range, 0–33 days); that
for patients without fenestration was 0 days (range, 0-5
days). Median intensive care unit stay for patients with fen-
estration was 3 days (range, 1–33 days); that for patients
without fenestration was 2 days (range, 1–22 days). Median
hospital stay for patients with fenestration was 8 days (range,
4–56 days); that for patients without fenestration was 8 days
(range, 1–85 days). The median time with chest tubes inTABLE 2. Operative data for primary Fontan Palliations by surgical tech
Technique Crossclamp time (min)
Extracardiac conduit (n ¼ 157) 10.9  26.7*
Concomitant procedure (n ¼ 24) 49  40.2
No concomitant procedure (n ¼ 133) 4  15.8
Lateral tunnel (n ¼ 69) 92.3  33.2
Concomitant procedure (n ¼ 26) 93  36.6
No concomitant (n ¼ 43) 92  31.4
All data are mean  SD. *P< .001 versus lateral tunnel. CPB, Cardiopulmonary bypass.
The Journal of Thoracic and Caplace for patients with fenestration was 5 days (range, 1–26
days); that for patients without fenestration was 5.5 days
(1–23 days). No patient was discharged home with a chest
drain in place.
Readmission within 1 month of discharge was for effu-
sion in 37 patients, for wound infection in 5 patients, and
for various, less acute reasons in 12 patients. The readmis-
sion rate for effusion among patients with fenestration was
16.8% (16/95); that among patients without fenestration
was 16.0% (21/131). Discharge oxygen saturation for pa-
tients with fenestration averaged 91%  4%; that for pa-
tients without fenestration averaged 93% 5% (P¼ .283).
Total hospital charges for patients undergoing Fontan pro-
cedures were collected for the years 2004 through 2008.
Mean charges during this period were $53,492.08 
$40,654.57. Total charges during the years studied did not
vary significantly (data not shown). There was a trend
(P¼ .105) toward increased hospital charges for fenestrated
($58,728.15  $43,502.40) versus nonfenestrated Fontan
operations ($50,785.31  $39,017.07). Similarly, there
was a trend (P ¼ .115) toward increased hospital charges
for the lateral tunnel technique ($62,058.09  $49,572.82)
versus the extracardiac technique ($50,615.44 
$36,957.40). These trends existed despite the differences
in era.
Late follow-up was performed by review of clinic, hospi-
tal, and referring physician records. Mean length of follow-
up was 2.0 1.7 years (range, 0–7 years). Table 5 shows the
late outcomes for patients with and without fenestration,
demonstrating that the reintervention rate was significantly
higher in the group with fenestration. Indications for early
or late reoperation included mediastinal exploration fornique
CPB time (min) Cooling temperature (C)
103.8  45.5* 31.9  3.9*
168  57.5 27  4.8
92  31.4 33  3.0
151.4  36 26.0  3.3
154  39.6 27  2.3
149  34 25  3.6
rdiovascular Surgery c Volume 140, Number 1 131
FIGURE 1. Relative use of extracardiac versus lateral tunnel technique
and association with overall fenestration. Numbers of patients with percent-
ages of fenestration are shown at bottom.
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Dbleeding in 1 patient, pacemaker placement in 5 patients,
pleurodesis or pericardial window in 8 patients, transplanta-
tion in 2 patients, and sternal procedures in 3 patients. Indi-
cations for early or late postoperative catheter interventions
included collateral occlusion in 8 patients, fenestration clo-
sure in 13 patients, pacemaker generator change in 3 pa-
tients, pulmonary arterial dilation or stenting in 4 patients,
diagnostic evaluation in 6 patients, atrial baffle dilation in
1 patient, thoracentesis in 1 patient, atrial puncture in 3 pa-
tients, dilation of coarctation in 1 patient, and pericardio-
centesis in 1 patient. There were no Fontan circulation
takedowns or revisions in the study population.
Late survival in Table 5 accounts for in-hospital deaths
and postdischarge deaths. Excluding the 3 in-hospital
deaths, late survival was 99.1% (221/223). Late survivals
by anatomic subtype were as follows: single left ventricle
100%, single right ventricle 99%, common ventricle
100%, and heterotaxy 97%, irrespective of the use of fenes-
tration (data not shown).
Multivariate regression was performed to identify vari-
ables affecting outcomes in patients undergoing FontanTABLE 3. Fenestration use and outcomes
2002 2003 2004
Total cases (no.) 16 31 27
Fenestrated (no.) 14 (87%) 20 (64%) 12 (44%)
ICU stay (d, mean  SD) 4.3  4.8 3  1.8 4.3  6.6
Hospital stay (d, mean  SD) 11.8  9.8 8.4  4 11.8  7.7
Discharge oxygen saturation
(%, mean  SD)
88  6.7 91.3  4.6 90.7  3.4
Early deaths (no.) 0 (0%) 1 (3.2%) 1 (3.7%)
Late deaths (no.) 1 (6.2%) 1 (3.2%) 0 (0%)
ICU, Intensive care unit.
132 The Journal of Thoracic and Cardiovascular Surgprocedures (Table 6). The variables included in the multivar-
iate analysis were ventricular morphology, intracardiac con-
comitant procedure, Fontan type, Fontan fenestration,
degree of systemic cooling, aortic crossclamp time, year of
surgery, and early extubation. None of the variables ana-
lyzed were predictive of early survival.
Ventricular morphology was identified on multivariate re-
gression as predictive of postoperative stay (P ¼ .008). Sin-
gle left ventricle was associatedwith an ICU stay of 2.6 2.4
days and a total postoperative stay of 9.0  9.0 days. Single
right ventricle was associated with an ICU stay of 3.7  5.0
days and a total postoperative stay of 11.0 6.1 days. Com-
mon ventricle was associated with an ICU stay of 5.7  7.4
days and a total postoperative stay of 14.2 15.2 days. Het-
erotaxy was associated with an ICU stay of 4.6  4.5 days
and a total postoperative stay of 12.8  8.2 days.
On multivariate analysis, Fontan technique (lateral tun-
nel) was predictive of longer ICU stay (P ¼ .022) and total
postoperative stay (P ¼ .017). Fontan type was not a signif-
icant predictor of outcome on univariate analysis. Patients
receiving extracardiac conduits had an ICU stay of 3.5 
4.2 days and a total postoperative stay of 10.9  8.4 days.
Similarly, patients undergoing lateral tunnel procedures
had an ICU stay of 3.8  4.8 days and a total postoperative
stay of 10.6 9.8 days. Aortic crossclamp duration was pre-
dictive of both ICU (P ¼ 0.037) and total postoperative
(P ¼ 0.016) stays on multivariate analysis.DISCUSSION
Management of patientswith single-ventricle anatomy un-
dergoing Fontan palliation has undergone significant evolu-
tion during the last 4 decades, with advances in surgical
techniques and perioperative strategies facilitating the
achievement of excellent results for these challenging pa-
tients.1-5 Fontan fenestration has been a traditional
mainstay of the surgical approach to improve early
outcomes,9-11 although we present data here strongly
suggesting that fenestration of the Fontan circuit is
necessary only in highly selected cases, irrespective of
single-ventricle anatomic subtype.Avoidance of fenestration
theoretically minimizes the risks of decreased oxygen2005 2006 2007 2008 Total
40 39 41 32 226
18 (45%) 14 (36%) 15 (37%) 2 (6%) 95 (42%)
4.6  6.5 3.2  3.1 3.6  3.4 2.5  2.3 3.6  4.4
12.7  12.1 10  6.1 11.4  12.3 9.3  2.8 10.8  8.8
93.1  4.6 92.7  3.5 93  4.2 92.4  4.1 92  4.5
1 (2.5%) 0 (0%) 0 (0%) 0 (0%) 3 (1.3%)
0 (0%) 0 (0%) 0 (0%) 0 (0%) 2 (1%)
ery c July 2010
TABLE 4. Comparison of early outcomes after fenestrated and
nonfenestrated Fontan procedures
Fenestrated Nonfenestrated P value
Intubation (d, mean  SD) 1.4  4.3 0  0.7 .002
ICU stay (d, mean  SD) 4.3  5.6 3.1  3.3 .039
Hospital stay (d, mean  SD) 11.8  9.6 10.9  8.3 .14
Chest tube (d, mean  SD) 6.0  3.5 6.6  4.5 .025
In-hospital deaths (no.) 2 (2%) 1 (1%) .38
Early readmissions (no.) 22 (23%) 32 (24%) .477
*Early readmissions were those within 30 days of discharge. ICU, Intensive care unit.
TABLE 6. Multivariate analysis of outcome predictors (P values)
Stay (d)
ICU Postoperative Operative survival
Ventricular morphology .068 .008 .932
Concomitant procedure* .538 .284 .593
Fontan type .022 .017 .181
Fontan fenestration .143 .407 .807
Lowest temperature .612 .932 .343
Crossclamp time .037 .016 .309
Year of Fontan .656 .571 .998
Early extubation (<24 h) .078 .516 .995
*Fontan procedure with concomitant intracardiac procedure. ICU, Intensive care unit.
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Dsaturation, systemic embolization, arrhythmias and heart
block, and need for late catheter interventions.9,12,13
The early and late outcomes presented here with a strategy
of highly selective Fontan fenestration are encouraging and
possibly even better than those after routine fenestrated Fon-
tan procedures. Other groups who have adopted this surgical
approach also report favorable outcomes.18-20 Fenestration
is reserved for the patients at highest risk, a group that
may include patients undergoing significant concomitant
procedures or single-lung Fontan palliation, those with
elevated pulmonary vascular resistance or transpulmonary
gradient, those with significant atrioventricular valve regur-
gitation or poor ventricular function, and those with intracar-
diac anatomy not amenable to extracardiac conduit.8,9,21
Advances in all aspects of patient management have col-
lectively enabled the results presented here for nonfenes-
trated procedures. With improved outcomes after first- and
second-stage single-ventricle palliation, better candidates
for completion Fontan procedures are referred for surgery.
Improved medical management and interstage surveillance
are also likely to have contributed. The population undergo-
ing Fontan procedures in the experience reported here is
somewhat older than that reported by others, which may fur-
ther contribute to a decreased need for fenestration.22
At our institution, the association between increased use of
the extracardiac technique and decreased fenestration is
clear. Extracardiac conduits for completion of total cavopul-
monary anastomosis minimize the need for cardiac arrest,
prolonged CPB, extensive atrial manipulation, and systemicTABLE 5. Late outcomes after fenestrated and nonfenestrated Fontan
procedures
Fenestrated Nonfenestrated Total P value
Reoperations 12 (12.6%) 7 (5.2%) 19 (8.4%) .04
Catheterization 28 (29.5%) 8 (6.1%) 36 (15.9%) .001
Late survival 92 (96.8%) 129 (98.5%) 221 (97.8%) >.10
Stroke 0 (0%) 0 (0%) 0 (0%) >.10
Transplant 1 (1.1%) 1 (0.8%) 2 (0.9%) >.10
Fontan takedown
or revision
0 (0%) 0 (0%) 0 (0%) >.10
All data represent numbers and percentages of patients. Mean follow-up 2.0  1.7
years.
The Journal of Thoracic and Cacooling.17,18 These advantages likely decrease the impact of
the surgical procedure on cardiopulmonary physiology,
thereby limiting the need for fenestration to support cardiac
output. With increased use of nonfenestrated extracardiac
conduits, measures of early morbidity such as hospital stay
and need for chest drains are not increased. Even for
patients who require intracardiac or other significant
concomitant procedures, an extracardiac Fontan procedure
lessens the myocardial ischemic time and may translate
into improved outcome. Furthermore, less systemic
cooling lower the impact on pulmonary physiology and
thus decrease the need for fenestration. Even for patients
with challenging intracardiac, caval, or pulmonary venous
anatomy, the extracardiac conduit has been applied with
excellent results.5,7,18,23 Groups performing the Fontan
procedure in a younger patient population and with
standard use of the intracardiac tunnel technique and
circulatory arrest routinely fenestrate.22 In the current era,
whether routine fenestration in the lateral tunnel Fontan pro-
cedure is indicated still remains to be evaluated.
Careful management of perfusion and anesthesia during
Fontan palliation likely contributes to the decreased need
for fenestration. At Texas Children’s Hospital, our perfusion
strategy emphasizes a physiologic pump prime, mainte-
nance of full CPB flow irrespective of systemic temperature,
aggressive ultrafiltration for removal of free water and in-
flammatory mediators, and careful attention to myocardial
protection. Having said this, other groups have advocated
extracardiac Fontan procedures without the use of CPB
and reported encouraging outcomes.24 Our approach has
been to use CPB for all Fontan palliations, because we be-
lieve that CPB facilitates a controlled, comprehensive proce-
dure without compromising outcomes.
Key elements of anesthetic management include the judi-
cious administration of opioids and sedation, the use of
regional anesthetic techniques, and a policy of early extuba-
tion.25 Fontan physiology is impaired with positive-pressure
ventilation.26 Our approach has therefore been aimed at
extubation in the operating room or very soon thereafter.25
The addition of dexmedetomidine to achieve sedation
without respiratory depression has further facilitated thisrdiovascular Surgery c Volume 140, Number 1 133
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Dstrategy.27 Immediate postoperative management is comple-
mentary, with emphasis on minimizing both volume admin-
istration and excessive sedation. Long-term anticoagulation
management is typically with aspirin alone. Other medical
management includes furosemide and afterload reduction,
as indicated.
In summary, we present our experience with highly selec-
tive use of fenestration during Fontan palliation. The data
support a nonfenestrated, extracardiac conduit technique
for Fontan palliation, irrespective of anatomic subtype,
with fenestration reserved for only the patients at highest
risk. Relying on improvements in all areas of medical and
surgical management, this strategy results in equal or better
surgical outcomes and fewer reinterventions. Further longi-
tudinal follow-up of this patient population, including func-
tional outcomes, will benefit the assessment of this approach
for patients with single-ventricle anatomy.
We thank all our team members at Texas Children’s Hospital for
their tireless dedication to and care of these patients. Without them,
these results for our patients undergoing Fontan palliation would
not be possible.References
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Dr Scott M. Bradley (Charleston, SC). You have nicely traced
the evolution of your group’s strategy through the last 7 years to
one that now includes use of an extracardiac conduit, with the
use of CPB, minimal use of aortic crossclamping, and decreasing
in use of fenestrations (only 6% of patients in the last year). You
have shown without question that this strategy can be used with
good outcomes, looking at all the usual outcome measures that
are examined for Fontan procedures. Both the use of this strategy
and your outcomes are in line with what has been described in pre-
vious publications, for example, those from the Stanford/University
of California San Francisco experience and from the Los Angeles
Children’s Hospital experience.
I have several questions. The first has to do with the duration of
pleural effusion drainage in your study, which ran about 6 days.
This was discussed in the debate yesterday, but there is certainly
a great deal of variation in the literature; some of this variation is
undoubtedly related to differences in management protocols for
chest tubes after Fontan procedures. Could you elaborate on your
group’s approach to postoperative management of chest tubes?
Specifically, when do you decide to remove chest tubes? Do you
have any consistent approach to the use of medications to try to
cut down on effusion drainage, such as angiotensin-converting en-
zyme inhibitors and diuretics?ery c July 2010
Salazar et al Congenital Heart Disease
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DDr Salazar.Our strategy for decreasing chest tube output begins
with aggressive ultrafiltration in the operating room, minimization
of fluid administration in the postoperative period, and a policy of
early extubation. With regard to timing of chest tube removal, all of
us at Texas Children’s Hospital are conservative and prefer to leave
the tubes in until minimal output has been demonstrated. Diuretic
administration is routine, preferring to see a mild increase in blood
urea nitrogen as a result of our diuretic management. Furthermore,
patients are fluid restricted to half or three-quarters maintenance to-
tal fluid intake for at least the first week after surgery.
Dr Bradley. Do you have any specific amount of chest
tube drainage that you use to decidewhen to take the chest tubes out?
Dr Salazar. I prefer to tailor that decision to the specific patient,
taking into account the clinical situation. As a general rule, we do
not remove drains until output has decreased below 1 mL/(kg $ d).
Dr Bradley. It appeared that approximately a quarter of your pa-
tients were readmitted. I assume that some of these were for treat-
ment of effusions?
Dr Salazar. Correct. Readmission was defined as occurring any
time within 1 month of discharge, to capture late readmissions.
More than half of those readmissions were for pleural effusion
management. Interestingly, the percentages of patients requiring re-
admission for effusion in the fenestrated and nonfenestrated groups
were equivalent.
Dr Bradley. If you were to include that period in the duration of
pleural effusion drainage and the stay data, both of those pieces of
information would probably look a bit different. That may be some-
thing you would want to consider putting in the article.
You now fenestrate very selectively. How do you decide in
which cases to fenestrate? Do you decide preoperatively or in the
operating room, and what specific criteria do you look at?
Dr Salazar. The decision to fenestrate is a clinical judgment
made in the operating room. Patients known to be at higher risk,
such as those receiving single-lung Fontan palliation, those with se-
vere atrioventricular valve regurgitation, and those with high pul-
monary vascular resistance are most likely to have fenestration.
The conduct of the operation also influences the fenestration de-
cision. If a significant period of cardiac arrest or even circulatory
arrest is required (although this is rare), then fenestration is more
likely. Fenestration is used to improve the early outcomes after
the Fontan operation. If preoperative and intraoperative variables
suggest a risk compromising the patient’s early postoperative
course, then we would fenestrate. Ultimately, it is a clinical judg-
ment that is based on the experience that fenestration is usually
not necessary.
Dr Bradley. So it sounds like a general gestalt of the patient’s
characteristics and how things are going in the operating room,
as opposed to specific hemodynamic criteria?
Dr Salazar. Ultimately, I agree.
Dr Bradley. Fair enough. Finally, I think it’s a bit more difficult
to fenestrate reliably extracardiac conduits than intra-atrial lateral
tunnels. Can you comment on your group’s technique?
Dr Salazar. Our technique is to fenestrate extracardiac con-
duits with the heart beating. We use a partial occlusion clamp
on the GORE-TEX conduit and atrium. An aortic punch is
used for the GORE-TEX conduit fenestration, although the depth
of sutures on the atrial side can influence the effective size of the
fenestration.The Journal of Thoracic and CaDr Bradley. So it’s side-to-side between the atrium and the out-
side of the GORE-TEX graft, as opposed to using a second tube
graft between the two?
Dr Salazar. That’s correct.
Dr Bradley. I think you have some information in your article
about the reliability of fenestration, specifically looking at postop-
erative systemic oxygen saturation. Can you just comment on the
postoperative oxygen saturation difference between the patients
with and without fenestration?
Dr Salazar.Most of the patients with fenestrated Fontan proce-
dures underwent the lateral tunnel technique. The lateral tunnel baf-
fle was fenestrated with an aortic punch, typically ranging in size
from 3 to 4 mm.
Interestingly, the discharge oxygen saturations were similar in
the patients with and without fenestration. This may reflect a less
ill patient population referred for Fontan palliation relative to 10
years ago. Decreasing preoperative transpulmonary gradients and
pulmonary vascular resistance, coupled with operations that mini-
mize the negative physiologic impact of surgery, have likely led
to less shunting across the fenestration.
Dr Bradley. So the numbers were, say, 92% versus 94%?
Dr Salazar. Average discharge saturations were 91% with fen-
estration and 93% without fenestration.
Dr Francois Lacour-Gayet (Aurora, Colo). I enjoyed your pre-
sentation. I understand that the rule now is no fenestration. Do you
believe that there is an exception for altitude? In Denver, we fenes-
trate all our Fontan procedures and would not dare not to fenestrate.
Can you elaborate on this and perhaps give us a limit, an altitude at
which you would consider not to fenestrate?
Dr Salazar. I appreciate your question, Dr Lacour-Gayet. Not
having lived or operated in Denver, I won’t presume to make
a general recommendation for the city. Having said this, the de-
creased partial pressure of oxygen at altitude likely translates into
some increase in pulmonary vascular resistance and reactivity. I
would proceed cautiously and base recommendations on clinical
experience.
Dr James S. Tweddell (Milwaukee, Wis). You were talking
about aggressive use of diuretics. What specific diuretics are you
using?
Dr Salazar.Most of the time, we use furosemide alone for post-
operative diuresis. Our dose typically is 1 mg/kg, administered 2 or
3 times a day. Some may not consider that aggressive, but that is
what I’m talking about.
Dr Tweddell.Did you ever consider using spironolactone in ad-
dition?
Dr Salazar.We have used spironolactone in addition to furose-
mide for those few patients with prolonged chest tube drainage.
Dr Frank L. Hanley (Stanford, Calif).When you do your side-
to-side fenestration with the punch and then you put the atrium
against that hole, do you put your sutures directly into the edge
of the punch when you’re actually making the surgical connection?
Dr Salazar. You mean to the inside?
Dr Hanley. When you’re bringing the atrium to the GORE-
TEX—I presume you use GORE-TEX?
Dr Salazar. Yes.
Dr Hanley. Are the sutures that go through the GORE-TEX go-
ing through the edge of the hole? I mean, are the sutures going into
the actual hole of the 4-mm punch?rdiovascular Surgery c Volume 140, Number 1 135
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DDr Salazar.Yes, I typically take thin bites of atrium and GORE-
TEX to avoid compromising the effective size of the fenestration.
Dr Hanley. If I could just make a suggestion?
Dr Salazar. Please do.
Dr Hanley. We used to do that, too. When you do that, if you
pick up too much of the atrium or the atrium is bulky, which is
not uncommon in a single ventricle, you will get a tunnel effect
to the fenestration because the atrial tissues impinge on the punch
hole, making the size of the hole unreliable.We prefer to put a large,
side-biting clamp on the GORE-TEX tube and then make the 4-mm
punch inside the relatively large surface area of GORE-TEX
sequestered by the clamp. We put another large, side-biting clamp
on the atrium, sequestering a relatively large surface area of atrium
as well. Then we make a long atriotomy, maybe 2 cm, and sew the
cut edge of the atrium onto the sequestered surface of the GORE-
TEX graft, at least half a centimeter if not more away from the136 The Journal of Thoracic and Cardiovascular Surgedge of the punch hole, onto the flat surface of the GORE-TEX.
So in the end, if you were sitting in the atrium and looking at that
atrial incision, you would see a 1.5-cm circle or oval of GORE-
TEX with a 4-mm punch in the middle of it. It is an undistorted
true 2-dimensional fenestration.
Dr Salazar. You have not had any problems with clots forming
in that area?
Dr Hanley. Not to our knowledge.
Dr Tweddell. I would just say that we use exactly the same tech-
nique. And actually I use the inferior vena cava, or the atrial end of
the inferior vena cava. You can use that to sew around the fenestra-
tion, just as Dr Hanley suggested, and we have not seen any conse-
quences. It gives you a reliable fenestration.
Dr Salazar. Thank you, and your point is well taken. The good
news is that, excepting the possibilities at high altitude, fenestration
of extracardiac conduits is rarely necessary.ery c July 2010
